Segment Information - Schedule of Significant Segment Expenses (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Segment Information [Line Items] | ||
| Research and development expenses (excluding stock compensation) | $ (679) | $ (4,716) |
| General and administrative expenses (excluding stock compensation) | (1,279) | (336) |
| Stock-based compensation | (467) | (4,451) |
| Other expense – direct listing offering costs | (586) | |
| Net loss and comprehensive loss | (2,544) | (5,052) |
| Lysosomal Storage Disorders Segment [Member] | ||
| Segment Information [Line Items] | ||
| Research and development expenses (excluding stock compensation) | (679) | (372) |
| General and administrative expenses (excluding stock compensation) | (812) | (229) |
| Stock-based compensation | (467) | (4,451) |
| Other expense – direct listing offering costs | (586) | |
| Net loss and comprehensive loss | $ (2,544) | $ (5,052) |
| X | ||||||||||
- Definition Other expense – direct listing offering costs. No definition available.
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|